Last updated on March 2017

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335


Brief description of study

The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of AL-335 in participants with various degrees of impaired renal function (mild, moderate, and severe) compared to participants with normal renal function.

Clinical Study Identifier: NCT02894905

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Orlando Clinical Research Center

Orlando Clinical Research Center
Orlando, FL United States
  Connect »

New Orleans Center for Clinical ...

New Orleans Center for Clinical Research
Knoxville, TN United States
  Connect »